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Adipose tissue, dietary lipids and de novo lipogenesis are sources of hepatic free fatty
acids (FFAs) that are stored in lipid droplets (LDs) as triacylglycerols (TAGs). Destiny of
TAGs stored in LDs is determined by LD proteomic equipment. When adipose triglyceride
lipase (ATGL) localizes at LD surface the lipid mobilization is stimulated. In this work,
an in vitro model of cultured rat hepatocytes mimicking a mild steatosis condition was
used to investigate the direct lipid-lowering action of iodothyronines, by focusing, in
particular, on LD-associated proteins, FFA oxidation and lipid secretion. Our results
demonstrate that in “steatotic” hepatocytes iodothyronines reduced the lipid excess
through the recruitment of ATGL on LD surface, and the modulation of the LD-associated
proteins Rab18 and TIP47. As an effect of ATGL recruitment, iodothyronines stimulated
the lipid mobilization from LDs then followed by the up-regulation of carnitine-palmitoyl-
transferase (CPT1) expression and the stimulation of cytochrome-c oxidase (COX) activity
that seems to indicate a stimulation of mitochondrial function. The lipid lowering action
of iodothyronines did not depend on increased TAG secretion. On the basis of our
data, ATGL could be indicated as an early mediator of the lipid-lowering action of
iodothyronines able to channel hydrolyzed FFAs toward mitochondrial beta-oxidation
rather than secretion.
Keywords: iodothyronines, primary cultured rat hepatocytes, in vitro steatosis, lipid lowering action, adipose
triglyceride lipase, lipid droplet, mitochondrial fatty acid oxidation
INTRODUCTION
Hepatic lipid accumulation results from both an increased uptake of circulating free fatty
acids (FFAs) rising from adipose tissue or dietary lipids, and/or de novo lipogenesis. Excess
lipid accumulation leads to hepatic steatosis which is characterized by the accumulation of
triacylglycerols (TAGs) in cytosolic lipid droplets (LDs) (Khor et al., 2013). LD accumulation
maintains low intracellular level of free fatty acids (FFAs) to avoid their toxic effects on cellular
physiology. LDs consist of a core of neutral lipids (mainly TAGs) that is bounded by a monolayer
of phospholipids and LD coat proteins. In the past, LDs were considered passive fat depots, but
now they are recognized as dynamic organelles at the hub of lipid and energy metabolism (Thiam
et al., 2013). The dynamicity of LDs is documented by changes in the expression of LD proteome
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that reflect the metabolic status of the cell and contribute in
regulating lipid metabolism and, ultimately, lipid homeostasis
(Pol et al., 2014). The most documented group of LD-associated
proteins is the perilipin (PLIN) family (Kimmel et al., 2010),
which comprises: perilipin (Plin1), adipophilin/ADRP (adipose
differentiation related protein; Plin2), TIP47 (tail-interacting
protein of 47 kDa; Plin3), S3-12 (Plin4) and OXPAT (oxidative
tissue-enriched PAT protein; Plin5; Bickel et al., 2009). Rab
proteins, as key regulators of membrane trafficking, are involved
in LD interactions (Murphy et al., 2009). Among the Rab family,
LD-associated Rab18 plays a crucial role in the vesicle trafficking
between LDs and other organelles (such as mitochondria,
peroxisomes, endoplasmic reticulum (ER)) and regulates LD
quantity and diameter by controlling fusion/fission processes
(Stenmark, 2009; Kiss and Nilsson, 2014). It is now accepted that
storage and release of FFAs from LDs result from variations in
the expression and/or activity of PLIN proteins and associated
lipases. According to metabolic needs, the hepatic lipases
dissociate non-esterified fatty acids (NEFAs) from TAGs for
oxidation, or alternatively, for re-esterification in the ER, where
TAGs are packaged into apolipoprotein-B-containing VLDL
(very low density lipoprotein) for secretion (Yao et al., 2013).
Adipose triglyceride lipase (ATGL) is now universally recognized
as the first and key enzyme that catalyzes the initial step in TAG
hydrolysis in both adipose and non-adipose tissues (Watt and
Steinberg, 2008). ATGL localizes at LD surface where it plays
an important role in LD degradation and lipid mobilization
(Smirnova et al., 2006). NEFAs resulting from TAG hydrolysis
are principally oxidized through mitochondrial and peroxisomal
beta-oxidation. Increases in fatty acid oxidation lead to the
stimulation of the respiratory chain, that is inevitably coupled
with reactive oxygen species (ROS) production. However,
mammalian cells are well equipped with many enzymatic
(such as catalase and superoxide dismutase) and non-enzymatic
(i.e., glutathione-GSH and metallothioneins-MTs) antioxidant
systems able to scavenge ROS.
Thyroid hormones (THs), thyroxine (T4) and 3,3
′,5-L-
triiodothyronine (T3), are widely known as key modulators
of energy balance and lipid metabolism. In the last decades,
even 3,5-diiodo-L-thyronine (T2) has been shown to exert
thyromimetic actions. In vivo and in vitro models of hepatic
steatosis have been used to demonstrate that T2 is able to both
prevent (Lanni et al., 2005; Grasselli et al., 2008, 2011a,b, 2012)
and reduce (Mollica et al., 2009) fat accumulation. Moreover,
T2 enhances mitochondrial respiration in both normothyroid
(Lombardi et al., 1998) and hypothyroid (Mangiullo et al., 2010;
Cavallo et al., 2013) rats by stimulating NEFA oxidation and
bioenergetics parameters. However, the hepatic targets of the
lipid-lowering effects of T2 are largely unknown.
In this study, we used an in vitro model of hepatic steatosis
to investigate the mechanisms underlying the lipid-lowering
action of iodothyronines (T3 and T2). Our results indicate that
both T3 and T2 induce ATGL recruitment at LD surface and
changes in the expression pattern of LD-associated proteins,
as well as up-regulation of CPT1 and stimulation of COX
activity thus suggesting a stimulation of the mitochondrial
function.
MATERIALS AND METHODS
Rat Hepatocyte Culture
Hepatocytes were isolated from adult male Wistar rats (Harlan-
Italy, S. Pietro al Natisone, Italy) and cultured as previously
described (Fugassa et al., 1983). Animal maintenance and
treatment were carried out according to the guidelines of
the European Community Council for animal care and use.
Twenty-four hours after plating, hepatocytes were incubated
with a mixture of NEFAs (oleate/palmitate 2:1 molar ratio, final
concentration 1.5mM) for 24 h (Grasselli et al., 2011a). Control
hepatocytes were incubated in the medium without addition
of NEFAs. Afterwards, medium was replaced by fresh D-MEM
containing T2 or T3 at two different concentrations (10
−6M and
10−5M) and the cells were incubated for 24 h. As controls (C),
hepatocytes were cultured with addition of the vehicle alone.
At the end of treatments, hepatocytes were collected and stored
at −80◦C until use. Cell viability, evaluated by Trypan blue
exclusion test, was greater than 90% and it was not affected by
treatments. For histological analyses, hepatocytes were cultured
and treated directly on collagen-coated glass slides (Falcon, BD,
Milano, Italy).
Histological and
ATGL-Immunohistochemical Staining
Hepatocytes were fixed with 4% buffered formalin. In intact cells,
neutral lipids were visualized using the soluble selective dye Oil
Red O (ORO) (Koopman et al., 2001). After treatments, slides
were washed with potassium phosphate buffer (PBS) and fixed
with 4% paraformaldehyde in PBS at 4◦C for 1 h, washed in
the same buffer and then incubated in 0.3% ORO solution as
previously described (Grasselli et al., 2010). ORO-stained cells
were then counterstained with haematoxylin and slides were
mounted in 10% glycerol in PBS.
ATGL was detected using anti-ATGL antibody (diluted 1:400,
cat no. ab85858; Abcam, Cambridge, UK). The immunoreaction
was revealed with the avidin-biotin-peroxidase complex (ABC)
method (Vector, Burlingame, CA, USA). Preparations were
examined using a Nikon light microscope (Nikon Eclipse 80i
microscope, Laboratory Imaging, Czech Republic) and ACT-2U
image analyzer linked to a Sony equipped with digital camera.
Lipid Quantification and Peroxidation
TAG content was quantified using the “Triglycerides liquid”
kit (Sentinel, Milan, Italy) that allows to quantify glycerol
as a measure of insoluble TAGs extracted with chloroform-
methanol (v/v) mixture (Grasselli et al., 2010). A Varian Cary
50 spectrophotometer (Agilent, Milan, Italy) was used for
spectrophotometric analysis.
Lipid peroxidation was evaluated by the thiobarbituric
acid reactive substances (TBARS) assay using malondialdehyde
(MDA; 1,1,3,3-tetramethoxypropane) as a standard (Iguchi et al.,
1993).
Values obtained were normalized for the protein content
determined by the bicinchoninic acid (BCA) assay using BSA as a
standard (Wiechelman et al., 1988). Data are expressed as percent
TAGs content relative to controls.
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RNA Extraction and Real-Time
Quantitative PCR
Total RNA was extracted by using Trizol Reagent (Sigma-
Aldrich) according to the manufacturer’s instructions.
First-strand cDNA was synthesized using 200 RevertAid H-
Minus M-MuLV Reverse Transcriptase (Fermentas, Hannover
MD, USA) as described elsewhere (Grasselli et al., 2010).
Real-time quantitative (qPCR) reactions were performed in
quadruplicate in a final volume of 25µl using 1x SybrGreen
PCR Master Mix and were analyzed in 96-well optical reaction
by Chromo4 System PCR (Biorad, Monza, Italy) as previously
described (Grasselli et al., 2012). Primer pairs for the genes
under analysis (Table 1) were designed ad hoc starting from
the coding sequences of Rattus norvegicus available on the
GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/
GenbankSearch.html) and synthesized by TibMolBiol custom
oligosynthesis service (Genova, Italy). Amplification conditions
were as follows: 3min at 95◦C, followed by 5 s at 95◦C and 1min
at 60◦C or 64◦C for 40 cycles. A melting curve of qPCR products
(65–94◦C) was also performed to ensure the absence of artifacts.
The relative quantity of target mRNA was calculated by using the
comparative Cq method and was normalized for the expression
of GAPDH gene. The normalized expression of the target genes
was thus expressed as relative quantity of mRNA (fold induction)
with respect to controls (C) (Pfaﬄ, 2001).
Western Blot
For ATGL immunodetection, cells were lysed in buffer
containing 1% Triton and 1% Natrium deoxycholate. Thirty-
five to fifty micrograms of protein extract of each sample
were electrophoresed at 70mA on 12% SDS–polyacrylamide
gel (SDS-PAGE) (Laemmli, 1970). After electrophoretic run,
the gel was electroblotted onto a nitrocellulose membrane
using Towbin buffer (25mM Tris HCl, 192mM glycine, 20%
methanol; pH 8.3; Towbin et al., 1979). Then, membrane
was blocked for 1 h in 5% fat-free milk/PBS pH 7.4 solution.
As primary antibodies we used rabbit anti-human ATGL (sc-
365278) supplied by Santa Cruz Biotechnology (DBA, Milan,
Italy). Membranes were incubated overnight at 4◦Cwith primary
antibody in PBS, then washed twice in PBST buffer (0.1M
phosphate buffer, 0.0027M KCl, 0.137M NaCl, and 0.1% Tween
20, in PBS pH 7.4) and once in PBS. Then, membranes were
incubated with horseradish peroxidase (HRP)-conjugated goat
anti-mouse IgG (Sigma-Aldrich, Milan, Italy) or rabbit anti-
goat IgG (Biorad) as a secondary antibody in PBST for 1 h
at room temperature. Protein molecular weight markers were
from Biorad (Plus Protein™ Dual Xtra Standards). As loading
controls, membrane was stripped and reprobed with rabbit anti-
actin antibody (A2066; Sigma-Aldrich, Milan Italy) diluted 1:500
in 5% milk/PBS. Immune complexes were visualized using an
enhanced chemiluminescence western blotting analysis system
(Bio-Rad ChemiDoc XRS System). Western blot films were
digitized and band optical densities were quantified against
the actin band using a computerized imaging system and
expressed as Relative Optical Density (ROD, arbitrary units).
ROD of each band was expressed as percentage with respect to
controls.
TABLE 1 | Characteristics of the primer pairs used for RT-qPCR analysis.
PRIMER
NAME
Primer sequence
(5′ → 3′)
Annealing
temperature
(◦C)
Product
lenght
(bp)
Accession ID
GAPDH Fwd GACCCCTTCATTGA
CCTCAAC
60 136 DQ403053
GAPDH Rev CGCTCCTGGAAGA
TGGTGATGGG
Rab18 Fwd GGGACCTTGCAG
TTTGCAC
64 134 BC089957
Rab18 Rev CCCCCCCCTCAA
AAAACCCC
TIP47 Fwd GGAACTGGTGTCA
TCAACAG
60 108 NW_047865.1
TIP47 Rev GGTCACATCCAC
TGCTCCTG
ADRP Fwd CCGAGCGTGGTG
ACGAGGG
64 148 AAH85861
ADRP Rev GAGGTCACGGTC
CTCACTCCC
CPT1 Fwd CCGCTCATGGTC
AACAGCA
60 105 NM_031559
CPT1 Rev CAGCAGTATGGC
GTGGATGG
MT-1 Fwd CTGCTCCACC
GGCGG
60 123 AY341880
MT-1 Rev GCCCTGGGCAC
ATTTGG
MT-2 Fwd TCCTGTGCCACAG
ATGGATC
60 149 XM_001070713
MT-2 Rev GTCCGAAGCCTCT
TTGCAGA
ApoB100
Fwd
CGTGGGCTCCAG
CATTCTA
60 71 NM_019287.2
ApoB100
Rev
TCACCAGTCATTTCTG
CCTTTG
Blue-Native Page and Histochemical
Staining
Solubilization of mitochondrial membranes by detergents, blue-
native (BN) PAGE, staining, and densitometric quantification of
oxidative phosphorylation complexes were performed essentially
as described elsewhere, with minor modifications (Silvestri
et al., 2015). Briefly, cells were suspended in hypotonic buffer
(83mM sucrose, 10mM MOPS, pH 7.2), homogenized in a
tightly fitting glass-Teflon homogenizer, and mixed with 250mM
sucrose, 30mM MOPS, pH 7.2. After a 15min centrifugation
at 600 × g (4◦C), to remove broken cells, the mitochondrial
fraction was collected by a 15min centrifugation at 15,000 × g
(4◦C). The mitochondria-containing sediment was suspended in
1M 6-aminohexanoic acid, 50mM Bis-Tris-HCl, pH 7.0; then
the membrane proteins were solubilized by addition of 10%
(w/v) dodecylmaltoside (specific for solubilization of individual
respiratory chain complexes). Following a 15-min centrifugation
at 100,000 × g, Coomassie-G250 dye (5% in 1M aminohexanoic
acid) was added to the supernatant and the sample was applied
to a 6–13% gradient polyacrylamide gel for BN-PAGE. Each
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lane contained 15µg of mitochondrial protein extract. After
the runs, gels were fixed and stained with Coomassie Blue G.
The band patterns were scanned using an imaging system (Bio-
Rad model GS-800 densitometer). The areas of the bands were
expressed as absolute values (arbitrary units). In parallel, another
a electrophoretic run was performed and enzymatic colorimetric
reaction was carried out essentially as reported by others with
minor modifications (Zerbetto et al., 1997). Complex IV (COX)
activity was estimated by incubating BN-PAGE gels with 5mg 3.3
0-diaminobenzidine tetrahydrochloride (DAB) dissolved in 9mL
phosphate buffer (0.05 M, pH 7.4), 1mL catalase (20µg/mL),
10mg cytochrome c, and 750mg sucrose. The intensity of
the reactive bands was normalized relative to the intensity
of the corresponding bands detected by Coomassie Blue G
staining.
Statistics
Data on both q-PCR and western blot are means ± S.D. of at
least four independent experiments performed in triplicate. Data
on enzyme activity are means± S.D. of at least three independent
experiments. Statistical analysis was performed by using ANOVA
followed by Bonferroni post hoc test.
RESULTS
Effects of Iodothyronines on ATGL
Recruitment on LD Surface
Primary rat hepatocytes exposed for 24 h to a mixture of NEFAs
(oleate/palmitate 1.5mM) mimic a mild steatosis condition that
is reversed by treatment with T2, or T3, for 24 h. ORO staining
and microscopic analysis evidenced small (maximum diameter
3.3µm) and few (maximum 5 LDs/cell) lipid droplets diffused
throughout the cytoplasm of control hepatocytes (Figure 1A).
In “steatotic” hepatocytes, the excess fat led to an increase in
both the number (maximum 15 LDs/cell) and the size (maximum
diameter 20µm) of LDs, with respect to controls (Figure 1B).
Treatment of steatotic hepatocytes with both T2 and T3 was
associated with a halving of both LD parameters (maximum
diameter was reduced to about 10µm and maximum number to
7 LDs/cell; Figures 1C,D).
The recruitment of ATGL on LD surface was assessed by
immunostaining (Figures 1E–H). While in control hepatocytes,
cytosol was punctuated by small ATGL-positive droplets
(Figure 1E), in “steatotic” hepatocytes, fat accumulation was
accompanied by a reduction in the number of small ATGL-
positive droplets, with the appearance of numerous and large
ATGL-negative droplets (Figure 1F). The lipid-lowering effect of
T2 or T3 (10
−5M) led to the reappearance of numerous small
ATGL-positive droplets, similarly to those observed in control
cells (Figures 1G,H).
The levels of ATGL protein were quantified by western
blot. No increase in ATGL content was observed in “steatotic”
hepatocytes with respect to controls (Figure 1I), but treatment
of “steatotic” cells with iodothyronines induced a significant
increase in ATGL protein levels (about +30% p < 0.05 for T2
and about+70% p < 0.01 for T3 with respect to “steatotic” cells).
Effects of Iodothyronines on the
Expression Proteins of LD
The mRNA expression of the LD-associated proteins Rab18,
TIP47, ADRP and OXPAT was assessed by qPCR (Figure 2).
In’steatotic’ cells, there was a significant up-regulation of Rab18
expression (about 1.60 folds, p ≤ 0.05 with respect to controls
Figure 2A) that was reduced when “steatotic” hepatocytes
were treated with T2 (about −35% for 10
−6M and −50% for
10−5M doses, p ≤ 0.05 and p ≤ 0.01 respectively, compared
to “steatotic” cells’). A similar effect was observed with T3
(about −40% for both doses, p ≤ 0.05 with respect to “steatotic”
cells).
A significant up-regulation of ADRP expression was recorded
in “steatotic” cells, whereas no changes in TIP47 mRNA
expression was observed in “steatotic” cells (Figure 2B). On
the other hand, TIP47 expression significantly decreased in
“steatotic” hepatocytes treated with the highest dose of T2 and
both doses of T3 (about -45% for T2 10
−5M; -50% for T3 10
−6M
and −40% for T3 10
−5M, p ≤ 0.05 with respect to “steatotic”
cells). No changes in ADRP expression were detected for any of
the concentration of T2 or T3 tested here. On the other hand,
neither T2 nor T3 affected Rab18 and TIP47 expression in control
cells (data not shown). We want to underline that no changes in
OXPAT expression were measured for all treatments tested here
(data not shown).
Effects of Iodothyronines on Mitochondrial
Function
As an index of mitochondrial oxidation of fatty acids we
evaluated the mRNA expression of CPT1, the rate-limiting
enzyme step for a major part of beta-oxidation. In “steatotic”
hepatocytes, the mRNA levels of CPT1 were up-regulated (about
2.00 fold p ≤ 0.05, with respect to controls Figure 3A). CPT1
expression was further increased when “steatotic” hepatocytes
were treated with T2 (about +165% for 10
−6M, and +115% for
10−5M doses, p ≤ 0.001 and p ≤ 0.01 respectively, compared
to “steatotic” cells). A similar effect was observed with T3
(about+140% for 10−6M, and+85% for 10−5M doses, p ≤ 0.01
and p ≤ 0.05 respectively, compared to “steatotic” cells). On
the other hand, neither T2 nor T3 affected CPT1 expression in
control cells (data not shown).
As an index of mitochondrial respiration, we measured the
activity of Complex IV using the enzymatic in-gel activity assay
(Figure 3B). No significant change in COX activity was observed
in’steatotic’ cells with respect to controls (Figure 3B). Treatment
of “steatotic” hepatocytes with the highest dose of both T2 and
T3 led to a significant stimulation in COX activity (about +124%
for T2 10
−5M, and +75% for T3 10
−5M; p ≤ 0.05, compared to
steatotic cells) On the other hand, neither T2 nor T3 affected COX
activity in control cells (data not shown). In all the experimental
conditions, no significant changes were observed as far as it
concerns the in-gel activities of both complex I and II.
Effects of Iodothyronines on Oxidative
Stress
The level of TBARS was assessed as a measure of lipid
peroxidation, a classical marker of oxidative stress. No significant
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FIGURE 1 | Effects of iodothyronines on lipid accumulation and ATGL recruitment/expression. Representative images of rat hepatocytes upon ORO (A–D)
and ATGL immunohistochemical (E–H) staining. The panels report control (A,E) and “steatotic” hepatocytes incubated in the absence (B,F) or in the presence of T2
(C,G) or T3 (D,H) (10
−5M) for 24 h. Nuclear staining with haematoxylin is also shown (Bar: 25µm). Histogram showing ATGL protein level as evaluated by western
blot (I). Actin was the protein loading control in SDS-PAGE. In the inset, a representative image of ATGL immune-reactive bands activity is reported (lane1: control,
lane2: NEFA, lane3: NEFA+T2 10
−5M/24 h, lane4: NEFA+T3 10
−5M/24h). Data (mean ± S.D. of at least four independent replicates) are expressed with respect to
controls taken as 100. Significant differences are reported (NEFA vs. THs, ##p ≤ 0.01 and #p ≤ 0.05).
changes in TBARS levels were detected as a response to
excess lipid accumulation (Figure 4B), thus confirming that
our experimental model mimics a mild steatosis condition.
Treatment of “steatotic” hepatocytes with both T2 and T3 did not
induce changes in TBARS levels.
Expression of metallothioneins, the main non-enzymatic
antioxidants together with glutathione, was determined by qPCR.
Lipid accumulation in “steatotic” cells was not associated with
significant changes in the expression of both metallothionein
isoforms MT-1 and MT-2 (Figure 4A). Treatment of “steatotic”
hepatocytes with the highest dose of both T2 and T3 showed a
significant down-regulation of both MT-1 (−40% for T2 10
−5M
and −35% for T3 10
−5M; p ≤ 0.001) and MT-2 (−45% for T2
10−5M and−40% for T3 10
−5M; p ≤ 0.001).
Neither T2 nor T3 affected TBARS levels or MT mRNA
expression in control cells (data not shown).
Effects of Iodothyronines on Lipid
Secretion
Total TAGs in the culture medium were quantified as a measure
of lipid secretion (Figure 5A). Excess lipid accumulation in
“steatotic” hepatocytes was associated with an increased TAG
content in the medium (+60%;p ≤ 0.01 with respect to controls).
Treatment of “steatotic” cells with either T2 or T3 (10
−5M) did
not induce any change in extracellular TAG content with respect
to’steatotic’ cells.
Expression of ApoB100, the main component of VLDL, was
also investigated (Figure 5B). A slight increase in ApoB100
mRNA expression was observed in’steatotic’ hepatocytes
(1.6 folds p ≤ 0.05 with respect to controls). Incubation
of “steatotic” cells with either T2 or T3 (10
−5M) did not
induce any change in ApoB100 expression with respect to
NEFA-treated cells. Neither T2 nor T3 affected ApoB100
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FIGURE 2 | Effects of iodothyronines on lipid droplet associated proteins. Relative mRNA expression of Rab18 (A) and TIP47(white) and ADRP (black) (B) was
evaluated by qPCR in control and “steatotic” cells incubated in the absence (NEFA) or in the presence of T2 or T3 (10
−6 and 10−5M, 24 h). GAPDH was used as the
internal control for quantifying gene expression. Data, expressed with respect to controls, are the mean ± S.D. of at least four experiments in triplicate. Significant
differences are denoted by symbols on bars (C vs. NEFA ***p ≤ 0.001 and *p ≤ 0.05; NEFA vs. THs #p ≤ 0.05).
FIGURE 3 | Effects of iodothyronines on mitochondrial oxidative capacity. Relative mRNA expression of CPT1 (A) was evaluated by qPCR in control and
“steatotic” cells incubated in the absence (NEFA) or in the presence of T2 or T3 (10
−6 and 10−5M, 24 h). GAPDH was used as the internal control for quantifying
gene expression. Data, expressed with respect to controls, are the mean ± S.D. of at least four experiments in triplicate. (B) In-gel activity of COX was evaluated by
BN-PAGE. Data expressed with respect to controls, are the mean ± S.D. of at least three independent experiments. A representative image of a Coomassie blue
stained BN-PAGE gel is reported (on the left). Molecular weights of standard proteins and the relative position of the respiratory complexes are indicated. In the inset, a
representative image of COX in-gel activity is also reported (lane1, control; lane2, NEFA; lane3, NEFA+T2 10
−5M/24 h; lane4, NEFA+T3 10
−5M/24 h). Significant
differences are denoted by symbols on bars (C vs. NEFA *p ≤ 0.05; NEFA vs. THs ###p ≤ 0.001; ##p ≤ 0.01; #p ≤ 0.05).
expression or TAG secretion in control cells (data not
shown).
DISCUSSION
Thyroid hormones exert pleiotropic effects on the entire
organism with a major role in modulating energy balance and
lipid metabolism. Previous studies by us (Grasselli et al., 2008)
and others (Lanni et al., 2005; Mollica et al., 2009) demonstrated
the ability of thyroid hormones in reducing lipid accumulation
in the liver. The direct effects of iodothyronines on hepatocytes
have been investigated by developing an in vitro model of
hepatic steatosis consisting of primary rat hepatocytes exposed
to a mixture of oleate/palmitate (Grasselli et al., 2011a). In
the present work, we demonstrate that the direct action of
iodothyronines in reducing lipid accumulation in hepatocytes
is due to an increased TAG mobilization from LDs likely
mediated by ATGL recruitment on LD surface. Moreover,
our data suggest that the excess FFAs deriving from ATGL
action are likely addressed to mitochondria for beta-oxidation
rather than to secretion as VLDL. Interestingly, despite the
stimulation of lipid catabolic pathways, the lipid-lowering effect
of iodothyronines is not associated with an increased rate of ROS
production.
The iodothyronine-driven lipid-lowering action led to a
reduction in total TAG content that parallels with the decrease
in both number and size of LDs, as previously documented
(Grasselli et al., 2011a). The effects of iodothyronines on LD
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FIGURE 4 | Effects of iodothyronines on oxidative stress. Relative mRNA expression of the two hepatic MT isoforms MT1 and MT2 (A) was evaluated in control
and “steatotic” cells incubated in the absence (NEFA) or in the presence of T2 or T3 (10
−5M, 24 h). GAPDH was used as the internal control for quantifying gene
expression. Extent of MDA production (B) was measured by TBARS assay. Data, expressed with respect to controls, are the mean ± S.D. of at least four experiments
in triplicate. Significant differences are denoted by symbols on bars (NEFA vs. THs ###p ≤ 0.001).
FIGURE 5 | Effects of iodothyronines on triglyceride secretion. (A) The extracellular TAG content was quantified in the culture medium in control and “steatotic”
cells incubated in the absence (NEFA) or in the presence of T2 or T3 (10
−5M, 24 h). The mRNA (B) levels of ApoB 100 were measured by qPCR, in control and
“steatotic” cells incubated in the absence (NEFA) or in the presence of T2 or T3 (10
−5M, 24 h). GAPDH was used as the internal control for quantifying gene
expression. Data, expressed with respect to controls, are the mean ± S.D. of at least four experiments in triplicate. Significant differences are denoted by symbols on
bars (C vs. NEFA *p ≤ 0.05, **p ≤ 0.01).
size might be of some significance. Indeed, large LDs provide
more efficient fat storage, whereas smaller LDs, with higher
surface/volume ratio, facilitate the release of their stored lipids
given the extensive surface accessible to lipases (Yu et al.,
2015). Among the different lipases, ATGL is now universally
recognized as the first and key enzyme in TAG hydrolysis in
both adipose and non-adipose tissues (Watt and Steinberg, 2008).
In this work, we show that the lipid-lowering effects exerted
by iodothyronines in vitro can be ascribed, at least partially, to
ATGL recruitment at the surface of LDs. In fact, in “steatotic”
hepatocytes ATGL-positive droplets are rare and small, whereas
numerous and large ATGL-negative LDs are present. Treatment
of “steatotic” hepatocytes with iodothyronine stimulates both
ATGL expression and recruitment at LD surface, suggesting an
increased hydrolysis rate of LD-stored TAGs.
The dynamic nature of LDs is now recognized and ascribed to
a proteomic equipment that varies depending on the metabolic
status of the cell and, ultimately, of the entire organism (Crunk
et al., 2013). In this context, we measured the expression of four
LD-associated proteins: Rab18, TIP47, ADRP, and OXPAT. The
latter did not change for all treatments tested. On the other
hand, in “steatotic” hepatocytes expression of Rab18 and ADRP
was induced. Treatment with iodothyronines induced a decrease
in the expression of both Rab18 and TIP47. Rab18 is a LD-
coating GTPase, whose role in lipid metabolism is still under
debate, but it seems to be involved in basal lipogenesis and
TAG accumulation (Kiss and Nilsson, 2014). Recently, several
Rab proteins have been localized to LD surface, and some
works revealed that GTP is a key mediator of LD-mitochondria
interaction. In fact, a biophysical study identified protein–protein
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contacts between the surface proteins of these two organelles
in yeast (Pu et al., 2011). TIP47 and ADRP seem to exert an
overlapping action on LD formation and TAG synthesis as well as
in protecting TAG from lipolysis (Sztalryd et al., 2006).Moreover,
absence/reduction of TIP47 at the LD surface could facilitate
the access of endogenous lipases, such as ATGL, to the stored
TAGs (Bell et al., 2008). Although our data cannot demonstrate
that the lipid-lowering effect of iodothyronines is directly due
to modulation of Rab18 and TIP47 expression, this hypothesis
cannot be discharged.
NEFAs released from LDs as a consequence of ATGL
activity are available as substrates for subsequent oxidation
(Reid et al., 2008). Fatty acid oxidation is increased by ATGL
overexpression and decreased by ATGL knockdown (Ong et al.,
2011). In this work, the stimulation of mitochondrial beta-
oxidation exerted by iodothyronines in “steatotic” hepatocytes
was suggested by two findings: (i) enhanced expression of CPT1
in order to increase entering of NEFAs into mitochondria; (ii)
stimulation of COX enzymatic activity, the last enzyme in the
respiratory electron transport chain of mitochondria. On the
other hand, iodothyronine treatment did not alter the number
of mitochondria (data not shown), thus indicating that the
observed increase in COX activity in vitro can be ascribed to a
direct action of iodothyronines on protein level and/or catalytic
activity of this enzyme. This findings are in line with previous
works demonstrating that the in vivo lipid-lowering action of
T2 is due to mitochondrial beta-oxidation stimulation (Lanni
et al., 2005; de Lange et al., 2011). Moreover, in vitro, a marked
increase in CPT1 expression upon iodothyronine treatment was
observed in FaO rat hepatoma cells, a model of rat hepatocytes
defective for thyroid hormone receptors (TR) (Grasselli et al.,
2011b), and this suggests that iodothyronines might exert their
action on mitochondria through both TR-dependent and non-
TR–dependent pathways converging on CTP1 expression. We
wish to underline that another site for NEFA catabolism resides
in peroxisomes, the main site for beta-oxidation of long- and
very long-chain NEFAs (Musso et al., 2009). We previously
showed that excess lipid accumulation is associated with an
increased activity of acyl CoA oxidase (AOX), the key enzyme
in peroxisomal oxidation of NEFA, but that iodothyronines
decreased AOX activity (Grasselli et al., 2011a). Taken together
our data indicate that the lipid-lowering effect of iodothyronines
is likely due to a stimulation of mitochondrial rather than
peroxisomal oxidation.
Generation of ROS by active mitochondria is very well known
as a cause of increased oxidative stress (Boveris and Chance,
1973). Our in vitro model of hepatic steatosis is not associated
to oxidative stress, since no changes were observed neither in
TBARS level nor in the expression of antioxidant molecules such
as MT-1 and MT-2. Even iodothyronine treatment of steatotic
hepatocytes did not rise TBARS level, indicating that neither
T3 nor T2 altered the oxidative homeostasis of the cell. The
finding that both T2 and T3 at higher concentration induced a
decrease in the mRNA levels of both MT-1 and MT-2 isoforms
is in accordance with previous data form ours demonstrating
a marked decrease in the activities of superoxide dismutase
and catalase when “steatotic” hepatocytes were incubated with
iodothyronines (Grasselli et al., 2011a).
NEFAs released from LDs can be subjected to another
pathway and can be readdressed to ER, re-esterified, packaged
and secreted as VLDL. Increasing VLDL secretion can be a
compensatory mechanism in fatty liver. In our in vitro model,
excess lipid accumulation induced an increase in ApoB100
expression and in the concentration of extracellular TAG, thus
indicating that “steatotic” hepatocytes try to overcome lipid
overload by increasing TAG secretion rate. On the other hand,
iodothyronines did not influence VLDL secretion or ApoB100
expression when administered to steatotic cells. Of note, these
data may be strictly dependent on the doses and the duration
of the used hormonal treatment, as well as on the in vitro
experimental conditions. Indeed, some recent in vivo data have
furnished different evidences: when administered to western
type diet fed low-density lipoprotein (LDL) receptors knockout
mice, thyroid hormones dramatically reduce circulating total
and VLDL/LDL cholesterol and this cholesterol reduction is
associated with decreased circulating levels of both ApoB48 and
ApoB100 (Goldberg et al., 2012).
Taken together, our data indicate that both T2 and T3 reduce
the fat content in “steatotic” hepatocytes by triggering ATGL
recruitment on LD surface and stimulating mitochondrial beta-
oxidation rather than TAG secretion and peroxisomal oxidation.
This is in accordance with previous report indicating that ATGL
knockdown is associated with decreased mitochondrial fatty acid
oxidation without any effects on TAG secretion (Ong et al.,
2011). In this scenario, ATGL could be considered a mediator
of the lipid-lowering action of iodothyronines on hepatocytes
by channeling hydrolyzed NEFA toward mitochondrial beta-
oxidation.
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